NO20000513L - Oligonukleotidreverstranskripsjonsprimere for effektiv detektering av HIV-1 og HIV-2 og metoder for anvendelse derav - Google Patents

Oligonukleotidreverstranskripsjonsprimere for effektiv detektering av HIV-1 og HIV-2 og metoder for anvendelse derav

Info

Publication number
NO20000513L
NO20000513L NO20000513A NO20000513A NO20000513L NO 20000513 L NO20000513 L NO 20000513L NO 20000513 A NO20000513 A NO 20000513A NO 20000513 A NO20000513 A NO 20000513A NO 20000513 L NO20000513 L NO 20000513L
Authority
NO
Norway
Prior art keywords
hiv
methods
effective detection
transcription primers
oligonucleotide transcription
Prior art date
Application number
NO20000513A
Other languages
English (en)
Other versions
NO20000513D0 (no
NO327727B1 (no
Inventor
David R Patterson
John A Puskas
Keming Song
Jeffrey M Linnen
Original Assignee
Ortho Clinical Diagnostics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Clinical Diagnostics Inc filed Critical Ortho Clinical Diagnostics Inc
Publication of NO20000513D0 publication Critical patent/NO20000513D0/no
Publication of NO20000513L publication Critical patent/NO20000513L/no
Publication of NO327727B1 publication Critical patent/NO327727B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/702—Specific hybridization probes for retroviruses
    • C12Q1/703—Viruses associated with AIDS

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • AIDS & HIV (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
NO20000513A 1999-02-02 2000-02-01 Fremgangsmate for revers transkribering og deteksjon av HIV-RNA i en biologisk prove, oligonukleotid og kit. NO327727B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11841799P 1999-02-02 1999-02-02

Publications (3)

Publication Number Publication Date
NO20000513D0 NO20000513D0 (no) 2000-02-01
NO20000513L true NO20000513L (no) 2000-08-03
NO327727B1 NO327727B1 (no) 2009-09-14

Family

ID=22378462

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20000513A NO327727B1 (no) 1999-02-02 2000-02-01 Fremgangsmate for revers transkribering og deteksjon av HIV-RNA i en biologisk prove, oligonukleotid og kit.

Country Status (13)

Country Link
US (1) US6303293B1 (no)
EP (1) EP1026263B1 (no)
JP (1) JP2000342274A (no)
KR (1) KR100901084B1 (no)
CN (1) CN1186455C (no)
AT (1) ATE397099T1 (no)
AU (1) AU761066B2 (no)
CA (1) CA2295920C (no)
DE (1) DE60038993D1 (no)
DK (1) DK1026263T3 (no)
ES (1) ES2306648T3 (no)
NO (1) NO327727B1 (no)
PT (1) PT1026263E (no)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6449507B1 (en) 1996-04-30 2002-09-10 Medtronic, Inc. Method and system for nerve stimulation prior to and during a medical procedure
US8036741B2 (en) 1996-04-30 2011-10-11 Medtronic, Inc. Method and system for nerve stimulation and cardiac sensing prior to and during a medical procedure
US7269457B2 (en) 1996-04-30 2007-09-11 Medtronic, Inc. Method and system for vagal nerve stimulation with multi-site cardiac pacing
US7225019B2 (en) 1996-04-30 2007-05-29 Medtronic, Inc. Method and system for nerve stimulation and cardiac sensing prior to and during a medical procedure
US6479523B1 (en) * 1997-08-26 2002-11-12 Emory University Pharmacologic drug combination in vagal-induced asystole
US7840278B1 (en) 1999-06-25 2010-11-23 Puskas John D Devices and methods for vagus nerve stimulation
DE60041489D1 (de) * 1999-07-09 2009-03-19 Gen Probe Inc Nachweis von hiv-1 durch amplifizierung von nukleinsäuren
CA2318730C (en) * 1999-09-20 2008-01-22 Ortho-Clinical Diagnostics, Inc. A method for reverse transcribing rna isolated in dry form
US6487446B1 (en) 2000-09-26 2002-11-26 Medtronic, Inc. Method and system for spinal cord stimulation prior to and during a medical procedure
ATE386821T1 (de) * 2000-10-23 2008-03-15 Gen Probe Inc Zusammensetzungen und methoden zur detektion von humanem immundefizienz virus 2 (hiv-2)
CA2547750C (en) * 2003-12-19 2014-04-08 Gen-Probe Incorporated Compositions, methods and kits for detecting the nucleic acids of hiv-1 and hiv-2
CN100340673C (zh) * 2005-02-03 2007-10-03 上海科华生物工程股份有限公司 人类免疫缺陷病毒hiv－1核酸扩增－荧光定量检测试剂盒
GB0701253D0 (en) 2007-01-23 2007-02-28 Diagnostics For The Real World Nucleic acid amplification and testing
WO2011119920A2 (en) 2010-03-25 2011-09-29 Oregon Health & Science University Cmv glycoproteins and recombinant vectors
US8639327B2 (en) 2010-04-29 2014-01-28 Medtronic, Inc. Nerve signal differentiation in cardiac therapy
US8620425B2 (en) 2010-04-29 2013-12-31 Medtronic, Inc. Nerve signal differentiation in cardiac therapy
US8406868B2 (en) 2010-04-29 2013-03-26 Medtronic, Inc. Therapy using perturbation and effect of physiological systems
US8706223B2 (en) 2011-01-19 2014-04-22 Medtronic, Inc. Preventative vagal stimulation
US8781582B2 (en) 2011-01-19 2014-07-15 Medtronic, Inc. Vagal stimulation
US8718763B2 (en) 2011-01-19 2014-05-06 Medtronic, Inc. Vagal stimulation
US8781583B2 (en) 2011-01-19 2014-07-15 Medtronic, Inc. Vagal stimulation
US8725259B2 (en) 2011-01-19 2014-05-13 Medtronic, Inc. Vagal stimulation
SMT201800284T1 (it) 2011-06-10 2018-07-17 Univ Oregon Health & Science Glicoproteine cmv e vettori ricombinanti
EP2568289A3 (en) 2011-09-12 2013-04-03 International AIDS Vaccine Initiative Immunoselection of recombinant vesicular stomatitis virus expressing hiv-1 proteins by broadly neutralizing antibodies
CN104066842A (zh) * 2012-01-25 2014-09-24 独立行政法人科学技术振兴机构 Hiv检测用寡核苷酸、hiv检测试剂盒及hiv检测方法
ES2631608T3 (es) 2012-06-27 2017-09-01 International Aids Vaccine Initiative Variante de la glicoproteína Env del VIH-1
EP2848937A1 (en) 2013-09-05 2015-03-18 International Aids Vaccine Initiative Methods of identifying novel HIV-1 immunogens
EP2873423B1 (en) 2013-10-07 2017-05-31 International Aids Vaccine Initiative Soluble hiv-1 envelope glycoprotein trimers
US10385410B2 (en) 2014-05-27 2019-08-20 Universite Paris Descartes In vitro method for the detection and quantification of HIV-2
US10174292B2 (en) 2015-03-20 2019-01-08 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers
US9931394B2 (en) 2015-03-23 2018-04-03 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers
CA3031994A1 (en) * 2016-07-29 2018-02-01 Juno Therapeutics, Inc. Methods for assessing the presence or absence of replication competent virus
ES2970989T3 (es) * 2016-09-07 2024-06-03 St Vincents Hospital Sydney Ltd Procedimientos de detección de VIH
CN106498095A (zh) * 2016-11-14 2017-03-15 湖南圣湘生物科技有限公司 一种人类免疫性缺陷病毒2型核酸检测试剂盒

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1715064B1 (fr) 1989-06-02 2009-02-25 Institut Pasteur Séquences nucléotidiques issues du génome des rétrovirus du type HIV-1, HIV-2 et SIV, et leurs applications notamment pour l'amplification de séquences de pol de ces génomes de ces rétrovirus et pour le diagnostic in vitro des infections dûes à ces virus
US5478724A (en) 1991-08-16 1995-12-26 The Rockefeller University Lentivirus-specific nucleotide probes and methods of use
JP3277045B2 (ja) 1992-10-06 2002-04-22 デイド・ベーリング・マルブルク・ゲゼルシヤフト・ミツト・ベシユレンクテル・ハフツング Ｈｉｖ−グループのレトロウイルスおよびその使用
US5599662A (en) * 1995-02-17 1997-02-04 Hoffmann-La Roche Inc. Oliconucleotide primers and probes for the detection of HIV-1
US5962665A (en) 1997-06-16 1999-10-05 Abbott Laboratories Nucleic acid primers and probes for detecting HIV-1 and HIV-2
US6001558A (en) * 1997-06-25 1999-12-14 Ortho Clinical Diagnostics, Inc. Amplification and detection of HIV-1 and/or HIV 2

Also Published As

Publication number Publication date
AU1482900A (en) 2000-08-03
KR100901084B1 (ko) 2009-06-08
CN1186455C (zh) 2005-01-26
CA2295920A1 (en) 2000-08-02
US6303293B1 (en) 2001-10-16
ATE397099T1 (de) 2008-06-15
EP1026263A3 (en) 2000-10-11
DE60038993D1 (de) 2008-07-10
EP1026263B1 (en) 2008-05-28
NO20000513D0 (no) 2000-02-01
EP1026263A2 (en) 2000-08-09
ES2306648T3 (es) 2008-11-16
DK1026263T3 (da) 2008-09-08
CN1271020A (zh) 2000-10-25
PT1026263E (pt) 2008-08-27
KR20010014470A (ko) 2001-02-26
AU761066B2 (en) 2003-05-29
NO327727B1 (no) 2009-09-14
CA2295920C (en) 2013-10-29
JP2000342274A (ja) 2000-12-12

Similar Documents

Publication Publication Date Title
NO20000513D0 (no) Oligonukleotid-reverstranskripsjonsprimere for effektiv detektering av HIV-1 og HIV-2 og metoder for anvendelse derav
DK0887427T3 (da) Amplifikation og detektion af HIV-1 og/eller HIV-2
NO20000536L (no) Oligonucleotide primere for effektiv detektering av Hepatitt C-virus (HCV) og metoder for anvendelse derav
DK1409544T3 (da) Humane DR4-antistoffer og anvendelser deraf
FR16C0028I2 (fr) Vecteurs viraux et utilisation de ces derniers dans des methodes therapeutiques
TR200002773T2 (tr) Alzheimer tedavisi için smilagenin ve anzurogenin-D ve bunların kullanımı.
ATE518553T1 (de) Vorrichtung und system zur sammlung von ausfluss von einer person
DE60023300D1 (de) Verwendung von cpg als adjuvans für hivimpstoff
TR199701669A1 (xx) Deri preparasyonu i�in bile�imler.
DE60041489D1 (de) Nachweis von hiv-1 durch amplifizierung von nukleinsäuren
AU3054502A (en) Compositions and methods for detecting human immunodeficiency virus 2 (hiv-2)
NO20000514D0 (no) Oligonukleotidprimere for effektiv multipleks deteksjon av Hepatitis C-virus (HCV) og human immunmangelvirus (HIV) og metoder for anvendelse derav
DE69727240D1 (de) Kombinationen enthaltend vx478, zidovudin und 3tc zur behandlung von hiv
DE60125537D1 (de) Zusammensetzung zur diagnose und behandlung von herpes simplex virusinfektionen
WO2002022076A3 (en) Means and methods for monitoring protease inhibitor antiretroviral therapy and guiding therapeutic decisions in the treatment of hiv/aids
EP1407042A4 (en) DEVICE AND METHODS FOR MONITORING ANTIRETROVIRAL THERAPY INHIBITING PROTEASE AND DETERMINING THERAPEUTIC DECISIONS IN THE TREATMENT OF HIV / AIDS
WO2001027330A3 (en) Screening for disease susceptibility by genotyping the ccr5 and ccr2 genes
EP1370697A4 (en) PEROXYREDOXIN-BASED MEDICINAL PRODUCTS FOR THE TREATMENT OF HIV-1 INFECTIONS AND METHODS OF USE
WO2004016228A3 (en) HTLV-I p30II AND p12I PROTEINS AS THERAPEUTIC TARGETS IN HTVL-I INFECTED INDIVIDUALS
이두식 et al. Detection of human immunodeficiency virus (HIV) type 1 provial sequences of peripheral blood mononuclear cells by using polymerase chain reaction
ATE198602T1 (de) Makrocyclische difluorostatonderivate als antivirale mittel
TR200000435T2 (tr) Bulaşıcı akdeniz humması geni.
CY1108543T1 (el) Εμβολια dna που κωδικοποιουν βοηθητικες πρωτεϊνες του hiv

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees